Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Kabra Drugs Annual General Meeting

Kabra Drugs Ltd shareholders approved a name change and alteration of the MOA object clause via postal ballot. Both resolutions passed with 99.85% votes in favor.

Source

BSE filing, NSE: KABRADG. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Kabra Drugs Ltd: key numbers

Share price
₹16.26
Market cap
₹38.55 Cr
Revenue (annual)
₹92.74 Cr
Net profit (annual)
₹4.96 Cr
P/E (TTM)
5.1×Sector 46.1×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Kabra Drugs Ltd

All →

Other annual general meeting announcements

All →